SoutheAsTern eUrope microciRculATION (SATURATION) registry - Design and rationale.
Natalija Odanovic, Konstantinos Tsioufis, Kyriakos Dimitriadis...
https://pubmed.ncbi.nlm.nih.gov/39672766/Actively Recruiting
Led by Institute for Cardiovascular Diseases Dedinje · Updated on 2024-05-14
900
Participants Needed
10
Research Sites
260 weeks
Total Duration
Researchers are evaluating adults with angina symptoms or angina equivalents who are referred for invasive coronary artery disease evaluation. This prospective multicenter registry studies patients undergoing coronary physiology testing using the Pressure Wire X and Coroflow Coroventis Cardiovascular System software. The study aims to assess regional patient selection practices, cardiovascular outcomes, and additional procedures performed after invasive coronary physiology evaluation. Participants receive invasive physiology testing, which may include microcirculation testing and vasospasm testing using the Coroflow Coroventis Cardiovascular system. Data collected at enrollment include demographic information, cardiovascular risk factors, prior events, medications, echocardiograms, ischemia testing, and procedure details including any complications. Follow-up visits occur every six months for up to five years to monitor major adverse cardiovascular events, medications, quality of life, angina symptoms, and ischemia testing. During follow-up, researchers collect data through direct patient contact or medical records to evaluate outcomes such as all-cause death, non-fatal heart attacks, coronary revascularization, hospitalizations, and stroke. Patient-centered measures include angina freedom using the Seattle Angina Questionnaire and quality of life with the EQ-5D-5L questionnaire. The total participation lasts up to five years with ongoing monitoring of cardiovascular health and related procedures.
CONDITIONS
Southeastern Europe Microcirculation Registry
I
Ivan S Ilić, MD, PhD
N
Natalija Odanovic, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Institute for Cardiovascular Diseases Dedinje
Lead Sponsor
Abbott Medical Devices
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of procedure
Participants undergo invasive coronary physiology testing including microcirculation testing and vasospasm testing using specialized cardiovascular systems to evaluate coronary artery disease.
1 visit (in-person)
Duration - Up to 5 years
Participants are followed up every 6 months for up to 5 years to monitor cardiovascular events, medications, quality of life, and angina symptoms through direct contact or follow-up visits.
Visits every 6 months for up to 5 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Natalija Odanovic, Konstantinos Tsioufis, Kyriakos Dimitriadis...
https://pubmed.ncbi.nlm.nih.gov/39672766/Institute for Cardiovascular Diseases Dedinje
Lead Sponsor
Abbott Medical Devices
Collaborating Sponsor